暗盘资金一眼洞悉庄家意图>> 草甘膦板块尾盘拉升，江天化学（300927）涨停，和邦生物（603077）、诺普信（002215）、利尔化学 （002258）、润丰股份（301035）、广信股份（603599）等纷纷走高。 ...

关 于 南 通 江 天 化 学 股 份 有 限 公 司 2024 年年度 股 东 大 会 的 法 律 意 见 书 北 京 大 成 (上 海 )律 师 事 务 所 www.dentons.cn 上海市世纪大道 100 号环球金融中心 9 层/24 层/25 层（200120） 9th/24th/25th Floor, Shanghai World Financial Center, No.100 Century Avenue Shanghai 200120, P. R. China Tel: +86 21 5878 5888 Fax: +86 21 5878 6866 dentons.cn 北京大成（上海）律师事务所 关于南通江天化学股份有限公司 2024 年年度股东大会的 法律意见书 致：南通江天化学股份有限公司 根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国 公司法》（以下简称"《公司法》"）和中国证券监督管理委员会《上市公司股东会 规则》等法律、法规和其他有关规范性文件的要求，北京大成（上海）律师事务 所（以下简称"本所"）接受南通江天化学股份有限公司（以下简称"公司"）的委 托 ...

证券代码：300927 证券简称：江天化学 公告编号：2025-023 南通江天化学股份有限公司 2024 年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示 1、 本次股东大会不存在否决议案的情形。 2、 本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1.召开时间： （1）现场会议召开时间：2025年5月9日（星期五）14:30 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025年5月9日9:15至9:25，9:30至11:30，13:00至15:00。通过深圳证券交易 所互联网投票系统进行投票的具体时间为：2025年5月9日9:15至15:00期间的任 意时间。 2.召开地点：南通开发区中央路16号公司四楼会议室 3.召开方式：采用现场表决与网络投票相结合的方式 4.召集人：公司董事会 5.主持人：公司董事长朱辉先生 6.会议召开的合法、合规性：经公司第四届董事会第十五次会议审议通过， 决定召开本次股东大会，会议召集、召开程序符合《公司法》《深圳证 ...

Group 1 - The A-share chemical and chemical engineering sector experienced a significant surge, with Danhua Technology and Jinpu Titanium Industry hitting the daily limit up [1] - Zhongyida saw an increase of over 8%, while Huiyun Titanium Industry and Jiangtian Chemical also rose [1]

Group 1 - The chemical sector has seen a significant rise, with Danhua Technology (600844) and Jinpu Titanium Industry (000545) hitting the daily limit up [1] - Zhongyida (600610) increased by over 8%, while Huiyun Titanium Industry (300891) and Jiangtian Chemical (300927) also experienced gains [1] Group 2 - Dark pool funds are flowing into these stocks, indicating increased investor interest [2]

Group 1 - Major shareholders of *ST WanFang plan to reduce their holdings by up to 9,341,596 shares, accounting for 3% of the company's total share capital from May 27 to August 25, 2025 [1] - Shareholders of Airo Energy intend to reduce their holdings by up to 800,000 shares, 800,000 shares, and 1,600,000 shares, representing 0.50%, 0.50%, and 1% of the company's total share capital respectively during the same period [1] - Anner plans to reduce its holdings by up to 3,186,159 shares, which is 1.5% of the company's total share capital, from May 27 to August 26, 2025 [1] Group 2 - Shareholders of Chuhuan Technology plan to reduce their holdings by up to 2,395,605 shares, accounting for 3% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [1] - Major shareholder of Dalian Technology intends to reduce their holdings by up to 4,189,336 shares, which is 0.99% of the company's total share capital from May 27 to August 26, 2025 [2] - Dongwei Technology's board members plan to reduce their holdings by a total of 2,574,857 shares, representing 0.8629% of the company's total share capital during the same period [2] Group 3 - Gann Li Pharmaceutical's shareholder has completed a reduction of 6,010,622 shares, which is 1% of the company's total share capital from April 22 to April 30, 2025 [2] - Guanshi Technology's board members plan to reduce their holdings by up to 359,375 shares, accounting for 0.4891% of the company's total share capital from May 27 to August 26, 2025 [2] - Guoguang Electric's shareholder has completed a reduction of 1,625,751 shares, which is 1.5% of the company's total share capital from April 25 to April 30, 2025 [2] Group 4 - Haili Biological's major shareholder has completed a reduction of 13,113,244 shares, representing 2% of the company's total share capital from April 15 to April 22, 2025 [3] - Hengfeng Information's board member has completed a reduction of 198,717 shares, which is 0.1207% of the company's total share capital on April 28, 2025 [3] - Hongwei Technology's shareholder plans to reduce their holdings by up to 820,000 shares, accounting for 0.39% of the company's total share capital from May 12 to August 11, 2025 [3] Group 5 - Huatai Medical's vice president has completed a reduction of 29,943 shares, which is 0.0308% of the company's total share capital from April 28 to April 29, 2025 [4] - Jilin Carbon Valley's major shareholder has completed a reduction of 4,989,160 shares, representing 0.8490% of the company's total share capital from April 25 to April 29, 2025 [4] - Jiahua Technology's shareholder plans to reduce their holdings by up to 1,160,000 shares, accounting for 1.50% of the company's total share capital from May 28 to August 25, 2025 [4] Group 6 - Jiangbo Long's shareholder plans to reduce their holdings by up to 4,159,815 shares, which is 1% of the company's total share capital from May 27 to August 26, 2025 [5] - Jiangshan Co. plans to reduce its holdings in Jiangtian Chemical by 4,330,800 shares, accounting for 3% of its total share capital from May 27 to August 26, 2025 [5] - Kairun Co.'s major shareholder plans to reduce their holdings by up to 9,000,000 shares, representing 2.43% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [5] Group 7 - Lianqi Technology's shareholders plan to reduce their holdings by a total of 18,717,374 shares, which is 2.96% of the total share capital excluding repurchased shares from May 27 to August 26, 2025 [9] - Zhongke Information's board members have completed a reduction of 698,914 shares, representing 0.2358% of the company's total share capital [9] - Zhongshi Co.'s major shareholder plans to reduce their holdings by up to 1,800,000 shares, accounting for 1.1527% of the company's total share capital from May 27 to August 26, 2025 [10]

Core Viewpoint - Jiangtian Chemical (300927.SZ) announced that its shareholder Jiangshan Co. plans to reduce its stake by up to 3% of the company's total shares between May 27, 2025, and August 26, 2025 [1] Summary by Relevant Categories Shareholder Actions - Jiangshan Co., holding 15.02% of Jiangtian Chemical, intends to reduce its holdings by no more than 4,330,800 shares, which represents up to 3.00% of the company's total share capital [1] Pricing and Methodology - The reduction will be executed through centralized bidding or block trading, with the selling price determined by the secondary market price, and will not be lower than the company's initial public offering price [1]

证券代码：300927 证券简称：江天化学 公告编号：2025-022 南通江天化学股份有限公司 大股东减持股份预披露公告 持股 5%以上的股东南通江山农药化工股份有限公司保证向本公司提供的信 息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 持有南通江天化学股份有限公司（以下简称"公司""发行人"）股份 21,690,000 股（占公司总股本比例 15.02%）的股东南通江山农药化工股份有限 公司（以下简称"江山股份"）计划在本减持计划公告发布之日起 15 个交易日 后的 3 个月内（即 2025 年 5 月 27 日至 2025 年 8 月 26 日）通过集中竞价或大宗 交易方式合计减持本公司股份不超过 4,330,800 股（占本公司总股本的比例为 3.00%），其中以集中竞价方式减持持有的公司股份不超过 1,443,600 股（即不 超过公司股份总数的 1%）；以大宗交易方式减持公司股票不超过 2,887,200 股 （即不超过公司股份总数的 2%）。 公司于近日收到江山股份出具的 ...

证券代码：300927 证券简称：江天化学 公告编号：2025-021 南通江天化学股份有限公司 关于2024年度利润分配方案的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.南通江天化学股份有限公司（以下简称"公司"）2024 年度的利润分配 方案为：以公司现有总股本 144,360,000 股为基数，向全体股东每 10 股派发现 金红利 0.90 元（含税），合计派发现金红利 12,992,400.00 元（含税）。本次 利润分配不送红股，不以资本公积金转增股本，剩余未分配利润结转以后年度分 配。 2.公司现金分红方案不涉及《深圳证券交易所创业板股票上市规则》第 9.4 条相关规定的可能被实施其他风险警示情形。 一、审议程序 公司于 2025 年 4 月 16 日召开第四届董事会第十五次会议、第四届监事会第 十三次会议，审议通过了《关于 2024 年度利润分配预案的议案》，本议案尚需 提交公司股东大会审议。 1.董事会审议情况 公司第四届董事会第十五次会议审议通过了《关于 2024 年度利润分配预案 的议案》。 董事会认为：该利润分配 ...